Libbs Farmaceutica Ltda-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Libbs Farmaceutica Ltda - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013940
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Libbs Farmaceutica Ltda (Libbs Farmaceutica) is a pharmaceutical company which offers biological drug products. The company offers monoclonal antibodies in various specialties which include cardiovascular, gynecology, oncology, dermatology, respiratory, and central nervous system transplant. It also offers active pharmaceutical ingredients, drugs and other medical products. Libbs Farmaceutica provides products in several dosage forms including injectable solutions, drops, tablets, capsules, coated tablets, powders, moisturizing fluids, gels and creams. The company carries its synthesis of active ingredients and manufacturing of medicines at its units located in Barra Funda and Embu das Artes, Sao Paulo. Libbs Farmaceutica is headquartered in Sao Paulo, Brazil.

Libbs Farmaceutica Ltda – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cristalia, Biolab, Eurofarma And Libbs Enter Into Joint Venture For Biological Medicines 10
Licensing Agreements 11
Libbs Farmaceutica to Enter into Licensing Agreement with Mithra Pharmaceuticals 11
BHV Pharma Enters into Licensing Agreement with Libbs Farmaceutica for Remogliflozin Etabonate 12
Libbs Farma Enters Into Licensing Agreement With mAbxience For Biosimilar Monoclonal Antibodies 13
Libbs Farmaceutica Ltda – Key Competitors 14
Libbs Farmaceutica Ltda – Key Employees 15
Libbs Farmaceutica Ltda – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Key Facts 2
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Libbs Farmaceutica Ltda, Deals By Therapy Area, 2011 to YTD 2017 8
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cristalia, Biolab, Eurofarma And Libbs Enter Into Joint Venture For Biological Medicines 10
Libbs Farmaceutica to Enter into Licensing Agreement with Mithra Pharmaceuticals 11
BHV Pharma Enters into Licensing Agreement with Libbs Farmaceutica for Remogliflozin Etabonate 12
Libbs Farma Enters Into Licensing Agreement With mAbxience For Biosimilar Monoclonal Antibodies 13
Libbs Farmaceutica Ltda, Key Competitors 14
Libbs Farmaceutica Ltda, Key Employees 15
Libbs Farmaceutica Ltda, Other Locations 16

★海外企業調査レポート[Libbs Farmaceutica Ltda-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sinovac Biotech Ltd (SVA):企業の財務・戦略的SWOT分析
    Summary Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, a an inactivated hepatitis A vaccine; bilive, a combined inactivated hepatitis A and B vaccine; anflu, a split viron influenz …
  • Pharmicell Co Ltd (005690):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmicell Co Ltd (Pharmicell), formerly Yuhaw Trade Co Ltd is a biopharmaceutical company that discovers, develops, and commercializes stem cell drugs. The company offers pipeline products such as Cellgram_AMI a heart disease drug, Cellgram_Lung a pulmonary disease drug, and Cellgram_IS and …
  • TE Connectivity Ltd (TEL):電力:M&Aディール及び事業提携情報
    Summary TE Connectivity Ltd (TE Connectivity), formerly Tyco Electronics Ltd, is a technology company. It designs and manufactures connectivity and sensor solutions. The company offers connectors; sensors; relays; heat shrink tubing; wire and cable; antennas and circuit protection devices. Its solut …
  • Astute Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Astute Medical Inc (Astute Medical), a subsidiary of BioMerieux SA is a diagnostic equipment provider. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through …
  • Fluor Corporation (FLR):電力:M&Aディール及び事業提携情報
    Summary Fluor Corporation (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other ser …
  • Ensign Energy Services Inc (ESI):企業の財務・戦略的SWOT分析
    Summary Ensign Energy Services Inc (Ensign Energy) is an oil and gas company that offers oilfield services. The company’s services include directional drilling, horizontal drilling, well servicing and testing services. It provides well completions and recompletions, abandonment of redundant wells, s …
  • University of Connecticut:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Connecticut (UCONN) is an educational service provider that offers graduation programs and other courses. The university offers undergraduate degree courses, graduate degree courses, professional degree programs, and research programs. It offers educational and training program …
  • Unum Group:戦略・SWOT・企業財務分析
    Unum Group - Strategy, SWOT and Corporate Finance Report Summary Unum Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Broadcom Inc (AVGO):企業の財務・戦略的SWOT分析
    Broadcom Inc (AVGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • TDK Corporation:戦略・SWOT・企業財務分析
    TDK Corporation - Strategy, SWOT and Corporate Finance Report Summary TDK Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Corporation Bank:企業の戦略・SWOT・財務情報
    Corporation Bank - Strategy, SWOT and Corporate Finance Report Summary Corporation Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Chemical Company of Malaysia Bhd (CCM):企業の財務・戦略的SWOT分析
    Chemical Company of Malaysia Bhd (CCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Airgain, Inc. (AIRG):企業の財務・戦略的SWOT分析
    Airgain, Inc. (AIRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Steris Plc (STE):企業の財務・戦略的SWOT分析
    Steris Plc (STE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sanford Health-製薬・医療分野:企業M&A・提携分析
    Summary Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center’s medical services include allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding disorders, botox …
  • PT Dian Swastatika Sentosa Tbk (DSSA):企業の財務・戦略的SWOT分析
    PT Dian Swastatika Sentosa Tbk (DSSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Double Bond Pharmaceutical International AB (DBPB):製薬・医療:M&Aディール及び事業提携情報
    Summary Double Bond Pharmaceutical International AB (DBP) is a pharmaceutical company that design, develop and commercialize therapies for cancer and autoimmune diseases. The company’s product pipeline includes SI-053 (Temodex), a novel therapy to treat malignant brain tumors; SA-033, SA-042, and SA …
  • Enterprise Products Partners LP (EPD):石油・ガス:M&Aディール及び事業提携情報
    Summary Enterprise Products Partners LP (Enterprise Products) is a provider of midstream energy services. The company‘s services include natural gas gathering, treating, processing, transportation and storage; transportation of natural gas liquids (NGL), fractionation, storage, and import and export …
  • CEMEX, SAB de CV:企業の戦略・SWOT・財務分析
    CEMEX, SAB de CV - Strategy, SWOT and Corporate Finance Report Summary CEMEX, SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hindustan ZInc Ltd:戦略・SWOT・企業財務分析
    Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆